Topeka Cancer Treatment

TOPEKA, Kan. (Feb. 3, 2026) — The University of Kansas Health System St. Francis Campus announces a major advancement in cancer care, successfully establishing full clinical capability to delivery bispecific antibody therapies (“BiTE” therapies) for eligible patients in Topeka and the surrounding region. Known as bispecific T-cell engager, or “BiTE,” therapies, these advanced immunotherapies help…